FDA takes bigger role in lowering drug prices

By Robert King

Published June 5, 2017 4:01am ET

Add Washington Examiner on Google

FDA takes bigger role in lowering drug prices — One of the moves Congress and the FDA are looking at is a loophole that major pharmaceutical companies use to stop generic makers from creating a cheaper copy. | malerapaso

The Food and Drug Administration isn’t standing on the sidelines anymore on fighting rising drug prices.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Congress FDA House of Representatives Patrick Leahy Pharmaceutical Industry Robert King